Fortis Healthcare Limited (NSE:FORTIS)
India · Delayed Price · Currency is INR 948.85
-3.20 (-0.34%)
Jul 30, 2026, 3:29 PM IST
Fortis Healthcare Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 91,278 | 77,828 | 68,929 | 62,976 | 57,176 | |
Revenue Growth | 17.28% | 12.91% | 9.45% | 10.14% | 41.87% |
Cost of Revenue | 36,197 | 32,005 | 29,239 | 39,894 | 24,923 |
Gross Profit | 55,082 | 45,823 | 39,690 | 23,082 | 32,253 |
Selling, General & Admin | 4,289 | 4,152 | 3,417 | 3,084 | 2,265 |
Other Operating Expenses | 30,065 | 25,887 | 23,691 | 8,997 | 19,340 |
Operating Expenses | 38,848 | 33,895 | 30,534 | 15,239 | 24,650 |
Operating Income | 16,234 | 11,927 | 9,156 | 7,844 | 7,603 |
Interest Expense | -2,704 | -1,444 | -936.01 | -985.87 | -1,194 |
Interest & Investment Income | 394.31 | 598.35 | 298.94 | 238.29 | 215.48 |
Earnings From Equity Investments | 163.52 | 115.23 | 95.1 | 218.4 | 241.47 |
Currency Exchange Gain (Loss) | 2.06 | -7.54 | -3.64 | 154.6 | 15.9 |
Other Non Operating Income (Expenses) | -246.83 | -262.29 | -228.25 | -178.43 | -188.94 |
EBT Excluding Unusual Items | 13,843 | 10,927 | 8,383 | 7,291 | 6,693 |
Impairment of Goodwill | - | - | - | - | -123.11 |
Gain (Loss) on Sale of Investments | 19.73 | 2.58 | 3.81 | 7.4 | - |
Gain (Loss) on Sale of Assets | 18.44 | 34.87 | 35.02 | 169.08 | 35.22 |
Asset Writedown | - | -393.78 | - | - | - |
Legal Settlements | -0.17 | -0.35 | -1.9 | -4.35 | -0.53 |
Other Unusual Items | -222.43 | -499.58 | 160.17 | 736.1 | 3,273 |
Pretax Income | 13,658 | 10,070 | 8,580 | 8,199 | 9,878 |
Income Tax Expense | 3,017 | 1,977 | 2,127 | 1,869 | 1,978 |
Earnings From Continuing Operations | 10,642 | 8,094 | 6,452 | 6,330 | 7,899 |
Net Income to Company | 10,642 | 8,094 | 6,452 | 6,330 | 7,899 |
Minority Interest in Earnings | -224.14 | -351.69 | -463.44 | -442.5 | -2,348 |
Net Income | 10,418 | 7,742 | 5,989 | 5,887 | 5,551 |
Net Income to Common | 10,418 | 7,742 | 5,989 | 5,887 | 5,551 |
Net Income Growth | 34.56% | 29.28% | 1.72% | 6.05% | - |
Shares Outstanding (Basic) | 755 | 755 | 755 | 755 | 755 |
Shares Outstanding (Diluted) | 755 | 755 | 755 | 755 | 755 |
Shares Change | - | - | - | - | - |
EPS (Basic) | 13.80 | 10.26 | 7.93 | 7.80 | 7.35 |
EPS (Diluted) | 13.80 | 10.26 | 7.93 | 7.80 | 7.35 |
EPS Growth | 34.56% | 29.32% | 1.69% | 6.10% | - |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | 6,559 | 5,770 | 1,576 | 3,750 | 6,499 |
Free Cash Flow Per Share | 8.69 | 7.64 | 2.09 | 4.97 | 8.61 |
Dividend Per Share | 1.000 | 1.000 | 1.000 | 1.000 | - |
Dividend Growth | 0% | 0% | 0% | - | - |
Gross Margin | 60.35% | 58.88% | 57.58% | 36.65% | 56.41% |
Operating Margin | 17.79% | 15.32% | 13.28% | 12.46% | 13.30% |
Profit Margin | 11.41% | 9.95% | 8.69% | 9.35% | 9.71% |
Free Cash Flow Margin | 7.19% | 7.41% | 2.29% | 5.96% | 11.37% |
EBITDA | 19,774 | 14,977 | 11,832 | 10,369 | 9,956 |
EBITDA Margin | 21.66% | 19.24% | 17.17% | 16.46% | 17.41% |
D&A For EBITDA | 3,541 | 3,050 | 2,676 | 2,525 | 2,353 |
EBIT | 16,234 | 11,927 | 9,156 | 7,844 | 7,603 |
EBIT Margin | 17.79% | 15.32% | 13.28% | 12.46% | 13.30% |
Effective Tax Rate | 22.09% | 19.63% | 24.80% | 22.80% | 20.03% |
Revenue as Reported | 91,785 | 78,497 | 69,312 | 63,594 | 57,449 |